These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4346780)

  • 41. Reduction of the pressor response to angiotensin and norepinephrine in the rat, induced by a renal peptide.
    Fasciolo JC; Risler NR
    Acta Physiol Lat Am; 1973; 23(6):521-2. PubMed ID: 4369126
    [No Abstract]   [Full Text] [Related]  

  • 42. Evidence for the existence of a sensitizing factor to pressor agents in the plasma of hypertensive patients.
    Mizukoshi H; Michelakis AM
    J Clin Endocrinol Metab; 1972 Jun; 34(6):1016-24. PubMed ID: 4336455
    [No Abstract]   [Full Text] [Related]  

  • 43. Antagonism of peripheral and central effects of angiotensin II by (1-sarcosine, 8-isoleucine)angiotensin II.
    Sweet CS; Ferrario CM; Khosla MC; Bumpus FM
    J Pharmacol Exp Ther; 1973 Apr; 185(1):35-41. PubMed ID: 4348281
    [No Abstract]   [Full Text] [Related]  

  • 44. [Proceedings: Effect of various hypertensive hormones in experimental nephrovascular hypertension in dogs].
    Kitagawa H; Yamaguchi S; Sato T; Mori Y; Nagai I
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):530. PubMed ID: 4375618
    [No Abstract]   [Full Text] [Related]  

  • 45. [Treatment of essential and nephrogenic hypertension using alpha-methyldopa and alpha-methyldopa+hydrochlorothiazide. Comparative study].
    Sales EJ; Villa JJ; Mendez MA
    Prensa Med Argent; 1971 Jun; 58(14):741-8. PubMed ID: 5091433
    [No Abstract]   [Full Text] [Related]  

  • 46. [Clinical results of therapy with alpha methyldopa, specially of its effect on the potassium content of serum and on the kidney function].
    Paquet KJ; Blittersdorf F
    Med Welt; 1967 Apr; 13():794-8. PubMed ID: 5584456
    [No Abstract]   [Full Text] [Related]  

  • 47. [The pressor response to angiotensin and to noradrenaline in subjects with hepatic diseases].
    Morandini G; Spanedda M; Spanedda L
    Minerva Med; 1967 May; 58(38):1794-8. PubMed ID: 4290843
    [No Abstract]   [Full Text] [Related]  

  • 48. Pressor response to angiotensin II in hypertension. Correlation with plasma renin activity and response to norepinephrine and metaraminol.
    Roguska J; Simon NM; del Greco F
    Am J Cardiol; 1968 May; 21(5):705-13. PubMed ID: 4296292
    [No Abstract]   [Full Text] [Related]  

  • 49. Natriferic and hydrosmotic effect of angiotensin II in the toad Bufo paracnemis.
    Coviello A
    Acta Physiol Lat Am; 1971; 20(4):349-58. PubMed ID: 4329189
    [No Abstract]   [Full Text] [Related]  

  • 50. A central effect of angiotensin: release of pituitary pressor material.
    Severs WB; Summy-Long J; Taylor JS; Connor JD
    J Pharmacol Exp Ther; 1970 Jul; 174(1):27-34. PubMed ID: 4393201
    [No Abstract]   [Full Text] [Related]  

  • 51. [Pressor effects of noradrenaline and tyramine in normotensive subjects and patients with essential hypertension and renovascular hypertension].
    D'Amelio G; Chioin R; Stritoni P; Cucchini F; Ferrari M
    Minerva Med; 1969 Dec; 60(97):4891-8. PubMed ID: 5357553
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of angiotensin on the pressor response to tyramine in normotensive subjects and hypertensive patients.
    Kaneko Y; Takeda T; Nakajima K; Ueda H
    Circ Res; 1966 Oct; 19(4):673-80. PubMed ID: 4288198
    [No Abstract]   [Full Text] [Related]  

  • 53. The effect of ultra lente insulin administration in rats.
    Apte BK; Chaudhury RR
    Indian J Physiol Pharmacol; 1964 Jul; 8(3):127-36. PubMed ID: 4284120
    [No Abstract]   [Full Text] [Related]  

  • 54. The direct effect of norepinephrine of angiotensin on the pulmonary veins of intact dogs.
    Hyman A
    J Pharmacol Exp Ther; 1969 Jan; 165(1):87-96. PubMed ID: 4302549
    [No Abstract]   [Full Text] [Related]  

  • 55. Pressor responses in portacaval transposition.
    Valcin A; Mathur A; Yang TS; Knopf M; Levowitz BS
    Surgery; 1972 Feb; 71(2):201-5. PubMed ID: 4333400
    [No Abstract]   [Full Text] [Related]  

  • 56. [Angiotensin II analogue and essential hypertension].
    Kono T; Ikeda F; Oseko F; Imura H; Shimbo S; Endo J
    Nihon Rinsho; 1979 Oct; 37(10):3503-10. PubMed ID: 392137
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of chronic intracerebroventricular infusion of angiotensin II on arterial pressure and fluid homeostasis.
    Fink GD; Bryan WJ; Mokler DJ
    Hypertension; 1982; 4(2):312-9. PubMed ID: 7068189
    [No Abstract]   [Full Text] [Related]  

  • 58. [The effect of alpha methyldopa and phenobarbital on angiotensin sensitivity and renin activity in man].
    Káldor A; Gachályi B; Kállay K; Fekete S; Földvári A
    Orv Hetil; 1975 Jan; 116(1):9-11. PubMed ID: 1088983
    [No Abstract]   [Full Text] [Related]  

  • 59. Hypotensive action and side effects of clonidine-chlorthalidone and methyldopa-chlorthalidone in treatment of hypertension.
    Amery A; Verstraete M; Bossaert H; Verstreken G
    Br Med J; 1970 Nov; 4(5732):392-5. PubMed ID: 4921284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interaction of angiotensin and noradrenaline in rat's hindlimb preparation. A possible mechanism of the experimental renal hypertension.
    Sato R; Masuyama Y
    Jpn Circ J; 1971 May; 35(5):505-9. PubMed ID: 4326118
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.